FDA Inspection 1107225 — Novo Nordisk A/S
The FDA completed an inspection of Novo Nordisk A/S on September 6, 2019 in Kalundborg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 6, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kalundborg (Denmark)